247 Cal.App.4th 1 (Cal. Ct. App. 2016) Cited 4 times 2 Legal Analyses
In Allergan, the District Court for the District of New Jersey simply included Pennsylvania in a list of jurisdictions that ostensibly allow a failure to warn claim based on a device manufacturer's inadequate reporting to the FDA under state law tort principles.